UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Critical care (London, England), 2019-11, Vol.23 (1), p.374-374, Article 374

2019

Volltextzugriff (PDF)

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Critical care (London, England), 2017-08, Vol.21 (1), p.213-213, Article 213

2017

Volltextzugriff (PDF)

Adrenal function in sepsis: The retrospective Corticus cohort study

Critical care medicine, 2007-04, Vol.35 (4), p.1012-1018

2007

Volltextzugriff (PDF)

Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: A multiple-center epidemiological study

Critical care medicine, 2005-02, Vol.33 (2), p.315-322

2005

Volltextzugriff (PDF)

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

The New England journal of medicine, 2001-03, Vol.344 (10), p.699-709

2001

Volltextzugriff (PDF)

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Critical care medicine, 2005-05, Vol.33 (5), p.952-961

2005

Volltextzugriff (PDF)

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The New England journal of medicine, 2004-08, Vol.351 (9), p.884-892

2004

Volltextzugriff (PDF)

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

ERJ open research, 2023-01, Vol.9 (1), p.342

2023

Volltextzugriff (PDF)

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Critical care (London, England), 2020-06, Vol.24 (1), p.289-289, Article 289

2020

Volltextzugriff (PDF)

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Thorax, 2014-11, Vol.69 (11), p.1034-1042

2014

Volltextzugriff (PDF)

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Critical care (London, England), 2020-07, Vol.24 (1), p.410-410, Article 410

2020

Volltextzugriff (PDF)

CT-proAVP IS NOT A GOOD PREDICTOR OF VASOPRESSOR NEED IN SEPTIC SHOCK

Shock (Augusta, Ga.), 2015-10, Vol.44 (4), p.330-335

2015

Volltextzugriff (PDF)

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Critical care (London, England), 2004-04, Vol.8 (2), p.R82-R90

2004

Volltextzugriff (PDF)

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (9), p.1024-1034

2021

Volltextzugriff (PDF)

The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study

PloS one, 2019-09, Vol.14 (9), p.e0223122-e0223122

2019

Volltextzugriff (PDF)

Convalescent Plasma for Covid-19-Induced ARDS. Reply

The New England journal of medicine, 2024-01, Vol.390 (4), p.386-386

2024

Volltextzugriff (PDF)

New Agents in Development for Sepsis: Any Reason for Hope?

Drugs (New York, N.Y.), 2020-11, Vol.80 (17), p.1751-1761

2020

Volltextzugriff (PDF)

Aerosol delivery during invasive mechanical ventilation: a systematic review

Critical care (London, England), 2017-10, Vol.21 (1), p.264-264, Article 264

2017

Volltextzugriff (PDF)

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Critical care medicine, 2018-09, Vol.46 (9), p.1436-1443

2018

Volltextzugriff (PDF)

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

Critical care medicine, 2003-01, Vol.31 (1), p.12-19

2003

Volltextzugriff (PDF)

Prognostic factors of acute mesenteric ischemia in ICU patients

BMC gastroenterology, 2019-05, Vol.19 (1), p.80-80, Article 80

2019

Volltextzugriff (PDF)

Immunotherapies for COVID-19: lessons learned from sepsis

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.946-949

2020

Volltextzugriff (PDF)

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

Kidney international, 2020-11, Vol.98 (5), p.1296-1307

2020

Volltextzugriff (PDF)

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

JAMA : the journal of the American Medical Association, 2013-03, Vol.309 (11), p.1154

2013

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(219)

Publikationsform

Artikel
(238)
Berichte
(9)
Webseiten
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Adrenal function in sepsis: The retrospective Corticus cohort study

A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: A multiple-center epidemiological study

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

CT-proAVP IS NOT A GOOD PREDICTOR OF VASOPRESSOR NEED IN SEPTIC SHOCK

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study

Convalescent Plasma for Covid-19-Induced ARDS. Reply

New Agents in Development for Sepsis: Any Reason for Hope?

Aerosol delivery during invasive mechanical ventilation: a systematic review

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

Prognostic factors of acute mesenteric ischemia in ICU patients

Immunotherapies for COVID-19: lessons learned from sepsis

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

Aktive Filter

Suchergebnisse filtern